Case Study: a USA Pharmaceutical Company achieves compliant, error-free regulatory publishing in South Korea with FREYR

USA Pharmaceutical Company cuts submission turnaround time by 70% with FREYR

The USA Pharmaceutical Company, a U.S.-based client, required regulatory publishing support for oral and parenteral products in South Korea. Their challenge involved reviewing study documents for eCTD compliance, managing end-to-end publishing activities, and handling last-minute document changes. FREYR provided Regulatory Publishing services to address these challenges.

FREYR implemented a solution that included creating detailed trackers for version changes, performing rigorous quality checks, and coordinating with a CRO. This resulted in a valid, error-free submission compliant with agency requirements. FREYR's work significantly reduced the overall turnaround time and provided cost benefits upwards of 70% for the client.